-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new crown virus (SARS-CoV-2) expression on vascular angiotensin converting enzyme cell has a receptor tropism
.
In the liver, these receptors appear to be expressed mainly in bile duct cells, with a much lower degree of expression in hepatocytes
The new crown virus (SARS-CoV-2) expression on vascular angiotensin converting enzyme cell has a receptor tropism
A total of 834 consecutive patients who were hospitalized due to COVID-19 were included in this study
.
Clinical, drug, and laboratory data are obtained through the medical record system database during admission and throughout the hospital stay
The study showed that a total of 105 (12.
6%) patients experienced significant liver damage during hospitalization
.
Compared with patients without significant liver damage, ischemia ([OR], 4.
This study confirmed that: COVID-19-related abnormal liver function is secondary to damage to other organs, mainly caused by ischemia or drug-induced liver injury.
COVID-19 will not directly cause liver insufficiency or death
.
COVID-19 will not directly cause liver insufficiency or death
.
Original source:
Michael Chew.
Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death.
Leave a message here